|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54.40 USD | -0.85% |
|
+2.98% | +81.99% |
| 07-27 | B. Riley Raises Price Target on TG Therapeutics to $86 From $55, Keeps Buy Rating | MT |
| 07-07 | Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says | MT |
| Market Cap | 7.78B 6.83B 6.38B 5.85B 10.96B 745B 11.23B 75.63B 29.58B 369B 29.2B 28.56B 1,274B | P/E 2026 * |
42.6x | P/E 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 7.77B 6.83B 6.37B 5.85B 10.95B 744B 11.22B 75.59B 29.56B 368B 29.18B 28.55B 1,273B | EV / Sales 2026 * |
8.25x | EV / Sales 2027 * | 5.55x |
| Free-Float |
88.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: TG Therapeutics, Inc.
| 1 day | -0.94% | ||
| 1 week | +2.98% | ||
| Current month | -1.26% | ||
| 1 month | -2.64% | ||
| 3 months | +61.55% | ||
| 6 months | +80.83% | ||
| Current year | +81.99% |
| 1 week | 51.28 |  | 57.58 |
| 1 month | 51.15 | | 59.3 |
| Current year | 26.76 | | 59.3 |
| 1 year | 25.28 | | 59.3 |
| 3 years | 6.46 | | 59.3 |
| 5 years | 3.48 | | 59.3 |
| 10 years | 3.32 | | 59.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 28/12/2011 |
Sean Power
DFI | Director of Finance/CFO | 44 | 28/12/2011 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 30/11/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 28/12/2011 |
Laurence Charney
BRD | Director/Board Member | 79 | 29/02/2012 |
Yann Echelard
BRD | Director/Board Member | 62 | 08/11/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/06/26 | Free | Director | 8,325 | 0.0054% | ||
| 11/06/26 | Free | Director | 8,325 | 0.0054% | ||
| 11/06/26 | Free | Director | 8,325 | 0.0054% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | +2.98% | +53.55% | +162.20% | 7.78B | |
| -0.29% | +4.67% | +59.56% | +167.81% | 1,089B | |
| -0.16% | +4.04% | +58.20% | +58.75% | 643B | |
| +1.21% | +4.97% | +39.05% | +77.76% | 465B | |
| -1.69% | +8.81% | +39.38% | +33.67% | 359B | |
| -0.51% | +3.51% | +36.97% | +42.46% | 303B | |
| +1.50% | +3.40% | +17.71% | +17.41% | 267B | |
| +0.79% | +5.81% | -2.55% | -38.10% | 226B | |
| -0.89% | +6.36% | +28.25% | +66.27% | 212B | |
| -0.04% | +2.86% | +17.37% | +76.08% | 167B | |
| Average | -0.09% | +4.74% | +34.75% | +66.43% | 373.89B | |
| Weighted average by Cap. | -0.03% | +5.13% | +42.59% | +81.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 943M 828M 773M 709M 1.33B 90.28B 1.36B 9.17B 3.58B 44.67B 3.54B 3.46B 154B | 1.29B 1.14B 1.06B 973M 1.82B 124B 1.87B 12.57B 4.92B 61.26B 4.85B 4.75B 212B |
| Net income | 200M 176M 164M 151M 282M 19.2B 289M 1.95B 762M 9.5B 753M 736M 32.85B | 483M 424M 396M 363M 680M 46.24B 697M 4.69B 1.84B 22.88B 1.81B 1.77B 79.1B |
| Net Debt | -4.69M -4.12M -3.85M -3.53M -6.61M -449M -6.77M -45.62M -17.84M -222M -17.61M -17.23M -769M | -601M -528M -493M -453M -847M -57.59B -868M -5.85B -2.29B -28.5B -2.26B -2.21B -98.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | US$54.23 | -1.17% | 1,554,017 |
| 28/07/26 | US$54.87 | -1.58% | 2,326,484 |
| 27/07/26 | US$55.75 | -0.52% | 1,680,373 |
| 24/07/26 | US$56.04 | +0.97% | 1,435,705 |
| 23/07/26 | US$55.50 | +5.35% | 2,961,244 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions
